A patent to kill? Comments on Resnik
Developing World Bioethics 2 (1):82–87 (2002)
| Abstract | This article has no associated abstract. (fix it) | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,701 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesSusan C. Hale (1990). Elementarity and Anti-Matter in Contemporary Physics: Comments on Michael D. Resnik's "Between Mathematics and Physics". PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1990:379 - 383.
Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton (2006). Patent Rights or Patent Wrongs? The Case of Patent Rights on AIDS Drugs. Business Ethics 15 (3):299–305.
David B. Resnik & Kenneth A. De Ville (2002). Bioterrorism and Patent Rights: "Compulsory Licensure" and the Case of Cipro. American Journal of Bioethics 2 (3):29 – 39.
David B. Resnik (2010). Review of Who Owns You?: The Corporate Gold Rush to Patent Your Genes. [REVIEW] Studies in Ethics, Law, and Technology 4 (1).
David B. Resnik (2004). Fair Drug Prices and the Patent System. Health Care Analysis 12 (2):91-115.
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2009-01-28Total downloads2 ( #232,575 of 549,113 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
